II. Medizinische Klinik und Poliklinik



Univ.-Prof. Dr. med. Roland M. Schmid

Direktor der II. Medizinischen Klinik und Poliklinik
Facharzt für Innere Medizin
Teilgebietsbezeichnung Gastroenterologie und Endokrinologie

Tel.: (089) 4140-2251
E-Mail: direktion.med2 [ at ] lrz.tum.de


Prof. Schmid leitet die II. Medizinische Klinik und Poliklinik seit dem 01. Oktober 2002. Er beschäftigt sich seit mehr als 20 Jahren medizinisch und wissenschaftlich mit der Diagnostik und Therapie von Krankheiten des Magen-Darm-Traktes. Ein besonderer Schwerpunkt sind Tumoren des Gastrointestinaltraktes, vor allem des Pankreas, der Gallengänge und der Leber.

Schule/Studium

1966 - 1970

1970 - 1979

1979 - 1985


 

Grundschule in Weingarten

Albert-Einstein-Gymnasium in Ravensburg

Medizin-Studium an der Universität in Ulm

Facharztausbildung

1987

 

Promotion zum Dr. med.
„Einfluß von Glucose, Insulin und Opiaten auf die neuroendokrine Regulation im Magen“

„summa cum laude“
Universität Ulm

 1995

 

 Habilitation für Innere Medizin
„Reinigung, Klonierung und Charakterisierung des Transkriptionsfaktors NF-KB“

Medizinische Fakultät, Universität Ulm


1995

 

Ernennung zum Privatdozenten, Medizinische Fakultät, Universität Ulm

1996

2000

2001

 

Facharzt für Innere Medizin

Ernennung zum Hochschuldozenten, Abteilung Innere Medizin I

Verleihung der Bezeichnung „außerplanmäßiger Professor“

 Weitere Qualifikationen

1999

2002

2005

 

Teilgebietsbezeichnung Gastroenterologie

Teilgebietsbezeichnung Endokrinologie

Executive EMBA, Universität St. Gallen
 

 Berufliche Tätigkeit

1986 - 1989

 

Wissenschaftlicher Assistent II. Medizinische Klinik,
Klinikum rechts der Isar der Technischen Universität München

1993 - 1997

 

Assistenzarzt Abteilung Innere Medizin I,
Universität Ulm

1997 - 2002

 

Leitender Oberarzt, Abteilung Innere Medizin I,
Universitätsklinikum Ulm

2002

 

C4-Professur Innere Medizin, Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie der Technischen Universität München, Klinikum rechts der Isar, II. Medizinische Klinik
 

 Forschungsaufenthalte

1989

 

Research Fellow am Department für Physiology, Ann Arbor, University of Michigan, Medical School, USA

1989 – 1990

 

Research Fellow am Department of Human Genetic, Prof. Meisler, Ann Arbor, University of Michigan Medical School, USA

1990 – 1993

 

Research Associate am Department of Biological Chemistry and Internal Medicine, Prof. Nabel, Howard Hughes Medical Institute,
Ann Arbor, University of Michigan Medical School
 

 Auszeichnungen

1986

 

Wolf-Boas-Preis,
Deutsche Gesellschaft für Verdauungs- und Stoffwechselerkrankungen, Salzburg

1998

 

Ludwig-Heilmeyer-Medaille in Silber,
Deutsche Gesellschaft für Fortschritte in der Inneren Medizin, Köln

2001

2002

2002

2004

2005

2006

 

Merckle-Forschungspreis der Universität Ulm

Editorial Board of Gastroenterology

Council International Association of Pancreatology

Editorial Board of DIGESTION

Editorial Board of World Journal of Gastroenterology

Associated Editor of Gastroenterology
 

 Patente

Gary J. Nabel, Roland M. Schmid, Neil D. Perkins.
U.S. Patent No. RE 33,823: "Proteins useful in the regulation of NFkB-containing genes", 1998.

 Mitgliedschaften

Deutsche Gesellschaft für Innere Medizin

Deutsche Gesellschaft für Fortschritte in der Inneren Medizin

Deutsche Gesellschaft für Verdauungs- u. Stoffwechselkrankheiten

Vereinigung der Bayerischen Internisten

Deutsche Krebsgesellschaft

Deutsche Gesellschaft für Immunologie

Arbeitsgemeinschaft Universitärer Gastroenterologen

Deutscher Pankreasclub

Gesellschaft für Biochemie und Molekularbiologie

Europäischer Pankreasclub

International Association of Pancreatology

American Gastroenterological Association

American Society of Clinical Oncology

American Association of Cancer Research

American Pancreatic Association

American College of Physician Executives

Publikationen
1986
1.
Schusdziarra V, Schmid R, Classen M Effect of insulin on secretion of bombesin-like immunoreactivity and gastrin from the isolated rat stomach in response to acetylcholin, VIP and leucine-enkephaline. Neuropeptides 1986;7:51-62.
2.
Schusdziarra V, Schmid R, Bender H, Schusdziarra V, Rivier J, Vale W, Classen M Effect of vasoactive intestinal peptide, peptide histidine isoleucine and growth hormone-releasing factor-40 on bombesin-like immunoreactivity, somatostatin and gastrin  release from the perfused rat stomach. Peptides 1986;7:127-133.
3.
Schusdziarra V, Schmid R, Classen M. Modulatory glucose effect on bombesin-like immunoreactivity and gastrin secretion from isolated perfused rat stomach. Diabetes 1986;35:791-796.
1988
4.
Schmid R, Schusdziarra V, Classen M. Modulatory effect of glucose on VIP-induced gastric somatostatin release. Am J Physiol-Endoc M 1988;254:E756-E759.
5.
Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M. Role of amino acids in stimulation of postprandial insulin, glucagon and pancreatic polypeptide in humans. Pancreas 1989;4:305-314.
1989
6.
Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M. Circulating amino acids and pancreatic endocrine function after ingestion of a protein-rich meal in obese subjects. J Clin Endocrinol Metab 1989;68:1106-1110.
7.
Schmid R, Schusdziarra V, Schulte-Frohlinde E, Maier V, Classen M.
Effect of CCK on insulin, glucagon, and pancreatic polypeptide levels in humans. Pancreas 1989;4:653-661.
1990
8.
Schmid R, Schusdziarra V, Aulehner R, Weigert N, Classen M. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas. Z Gastroenterol 1990;28:280-284.
9.
Schmid R, Schusdziarra V, Butscher H, Classen M. Composition of amino acid infusions and effect of cholecystokinin on insulin release in dogs. Clin Physiol Biochem 1990;8:244-249.
10.
Schmid R, Schusdziarra V, Allescher HD, Bofilias I, Buttermann G, Classen M. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Diabetes Care 1991;14:65-68.
11.
Schmid RM, Perkins ND, Duckett CS, Andrews PC, Nabel GJ. Cloning of an NF-?B subunit which stimulates HIV transcription in synergy with p65. Nature 1991;352:733-736
12.
Samuelson LC, Wiebauer K, Howard G, Schmid RM, Koeplin D, Meisler MH. Isolation of the murine ribonuclease gene Rib-1: structure and tissue specific expression in pancreas and parotid gland. Nucleic Acids Res 1991;19:6935-6941.
1992
13.
Schmid R, Schulte-Frohlinde E, Schusdziarra V, Neubauer J, Stegmann M, Maier V, Classen M Contribution of postprandial amino acid levels to stimulation of insulin, glucagon, and pancreatic polypeptide in humans Pancreas 1992;7:698-704.
14.
Weigert N, Dollinger M, Schmid R, Schusdziarra V Contribution of neural intrapancreatic non-cholinergic non-adrenergic mechanisms to glucose-induced insulin release in the isolated rat pancreas Diabetologia 1992;35:1133-1139.
15.
Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ. Distrinct combinations of NF-?B subunits determine the specificity of transcriptional activation. P Natl Acad Sci USA 1992;89:1529-1533
16.
Schmid RM, Meisler MH. Dietary regulation of pancreatic amylase in transgenic mice mediated by a 126-base pair DNA fragment. Am J Physiol-Gastr L 1992;25:G971-G976.
17.
Liu J, Perkins ND, Schmid RM, Nabel GJ. Specific NF-?B subunits act in concert with Tat to stimulate human immunodeficiency virus type transcription. J Virol 1992;66:3883-3887.
18.
Liptay S, Schmid RM, Perkins ND, Meltzer P, Altherr MR, McPherson JD, Wasmuth JJ, Nabel GJ. Related subunits of NF-?B map to two distinct loci associated with translocations in leukemia, NF?B1 and NF?B2. Genomics 1992;13:287-292.
1993
19.
Schulte-Frohlinde, E, Schmid R, Schusdziarra V. Effect of a postprandial amino acid pattern on gastric secretion in man. Z Gastroenterol. 1993; 31: 711-715
20.
Duckett CS, Perkins ND, Kowalik TF, Schmid RM, Huang ES, Baldwin Jr AS,Nabel GJ Dimerization of NF-?B2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I ?B-alpha (MAD-3). Mol Cell Biol 1993;13:1315-1322.
21.
Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. A cooperative interaction between NF-?B and Sp1 is required for HIV1 enhancer activation. EMBO J 1993;12:3551-3558.
22.
Potter DA, Larson CJ, Eckes P, Schmid RM, Nabel GJ, Verdine GL, Sharp PA. Purification of the major histocompatibility complex class I transcription factor H2TF1 The full-length product of the nf?b2 gene. J Biol Chem 1993; 268:18882-18890.
1994
23.
Schmid RM, Weidenbach H, Draenert GF, Lerch MM, Liptay S, Schorr J, Beckh KH, Adler G. Liposome mediated in vivo gene transfer into different tissues of the gastrointestinal tract. Z Gastroenterol 1994; 32: 665-670.
24.
Liptay S, RM Schmid RM, EG Nabel EG, GJ Nabel GJ. Transcriptional regulation of NF-?B2: evidence for ?B-mediated positive and negative autoregulation. Mol Cell Biol. 1994; 14: 7695-7703.
25.
Schmid RM, Liptay S, Betts JC, Nabel GJ. Structural and functional analysis of NF-?B: determinants of DNA binding specificity and protein interaction. J Biol Chem. 1994; 269: 32162-32167.
1997
26.
Schmid RM, Weidenbach H, Liptay S, Adler G. Direct gene transfer into the colon using a double-balloon catheter. Endoscopy. 1997; 29: 39-43.
27.
Liptay S, Seriu T, Bartram CR, Schmid RM. Germline configuration of NF?B2, c-rel and bcl3 in childhood acute lymphoblastic leukemia (ALL). Leukemia. 1997; 11: 1364-1366.
28.
Schmid RM, Weidenbach H, Draenert GF, Liptay S, Luhrs H, Adler G. Liposome mediated gene transfer into the rat oesophagus. Gut. 1997; 41: 549-556.
1998
29.
Oswald F, Liptay S, Adler G, Schmid RM. NF-?B is a putative target gene of activated Notch-1 via RBP-J?. Mol Cell Biol. 1998; 18:2077-2088.
30.
Gansauge S, Schmid RM, Muller J, Adler G, Mattfeldt T, Beger HG. Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Brit J Surg. 1998; 85: 337-340.
31.
Wahl C, Liptay S, Adler G, Schmid RM. Sulfasalazine: a potent and specific inhibitor of nuclear factor ?B. J Clin Invest. 1998; 101: 1163-1174.
32.
Schmid RM, Weidenbach H, Yamagushi H, Luhrs H, Liptay S, Adler G. Direct gene transfer into the rat pancreas using DNA-liposomes Eur J Clin Invest. 1998; 28: 220-226.
33.
Orth M, Gansauge F, Gansauge S, Beger HG, Adler G, Schmid RM. Kras mutations at codon 12 are rare events in chronic pancreatitis. Digestion. 1998; 59: 120-124.
34.
Liptay S, Weidenbach H, Adler G, Schmid RM. Colon epithelium can be transiently transfected with liposomes, calcium phosphate precipitation and DEAE dextran in vivo. Digestion. 1998; 59: 142-147.
35.
Bachem MG, Schneider E, Groß H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grunert A, Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998; 115: 421-432.
36.
Wagner M, Luhrs H, Kloppel G, Adler G, Schmid RM. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology. 1998; 115: 1254-1262.
37.
Schwarz SC, Seufferlein T, Liptay S, Schmid RM, Kasischke K, Foster OJF, Daniel S, Schwarz J. Microglial activation in multiple system atrophy: a potential role for NF-?B/rel proteins. NeuroReport. 1998; 9: 3029-3032.
38.
Friess H, Lu Z, Graber HU, Zimmermann A, Adler G, Korc M, Schmid RM,  Buchler MW. 1Bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut. 1998; 43: 414-421.
39.
Friess  H, Lu Z, Andren-Sandberg A, Berberat P, Zimmermann A, Adler G, Schmid R, Buchler MW. Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg. 1998; 228: 780-787.
40.
Hacker  H, Mischak H, Miethke T, Liptay S, Schmid RM, Sparwasser T, Lipford GB, Heeg K, Wagner H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J 1998;17:6230-6240.
41.
Gansauge F, Gansauge S, Schlosser W, Schmid RM, Adler G, Beger HG. The splice-pattern of CD44 is altered in chronic pancreatitis exhibiting dysplastic changes. Eur J Med Res 1998;3:419-426.
1999
42.
Graber HU, Friess H, Zimmermann A, Korc M, Adler G, Schmid R, MW Buchler MW. Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells. Gastrointest Surg 1999;3:74-81
43.
Steinle AU, Weidenbach H, Wagner M, Adler G, Schmid RM. NF-?B/Rel activation in cerulein pancreatitis. Gastroenterology. 1999;116:420-430.
44.
Gosslar U, Schmid RM, Holzmann B. Regulation of Egr-1-dependent gene expression by the C-terminal activation domain. Biochem Bioph Res Co 1999;255:208-215
45.
Song Q, Haller B, Schmid RM, Adler G, Bode G. Helicobacter pylori in dental plaque: a comparison of different PCR primer sets. Digest Dis Sci 1999;44:479-484.
46.
Rupec RA, Poujol D, Grosgeorge J, Carle GF, Livolsi A, Peyron JF, Schmid RM, Baeuerle PA, Messer G. Structural analysis, expression, and chromosomal localization of the mouse ikba gene. Immunogenetics 1999;49:395-403.
47.
Seufferlein T, Lint JV, Liptay S, Adler G, Schmid RM. Transforming growth factor alpha activates Ha-Ras in human pancreatic cancer cells with Ki-ras mutations. Gastroenterology 1999;116:1441-1452.
48.
Ebert MP, Hoffmann J, Haeckel C, Rutkowski K, Schmid RM, Wagner M, Adler G, Schulz HU, Roessner A, Hoffmann W, Malfertheiner P. Induction of TFF1 gene expression in pancreas overexpressing transforming-growth factor alpha. Gut 1999;45:105-111.
49.
Schwenzer R, Siemienski K, Liptay S, Schubert G, Peters N, Scheurich P, Schmid RM, H Wajant H. The human tumor necrosis factor (TNF) receptor associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-?B and c-Jun N-terminal kinase. J Biol Chem 1999;274:19368-19374
50.
Paxian S, Liptay S, Adler G, Hameister H, Schmid RM. Genomic organization and chromosomal mapping of mouse nuclear factor ?B 2 (NF?B2). Immunogenetics 1999;49:743-750.
51.
Grewe M, Gansauge F, Schmid RM, Adler G, Seufferlein T. Regulation of cell growth and cyclin D1 expression by the constitutively active FRAPp70s6K pathway in human pancreatic cancer cells. Cancer Res 1999 59:3581-3587.
52.
Klein BS, Liptay S, Schmid RM, Hameister H. Assignment of nf?bib to murine chromosome bands 7A3-B3 by in situ hybridization. Cytogenet Cell Genet 1999;85:308-309.
53.
Tando Y, Algul H, Wagner M, Weidenbach H, Adler G, Schmid RM. Caerulein-induced NF-?B/Rel activation requires both Ca2+ and protein kinase C as messengers. Am J Physiol-Gastr L 1999;277:G678-G686
54.
Liptay S, Bachem M, Hacker G, Adler G, Debatin KM, Schmid RM. Inhibition of nuclear factor ?B and induction of apoptosis in T-lymphocytes by sulfasalazine. Brit J Pharmacol 1999;128:1361-1369
2000
55.
Klein BS, Himmelbauer H, Zechner U, Riemann M, Liptay S, Hameister H, Schmid RM. Assignment of the mouse Rbpsuh gene to chromosome 5 and one processed pseudogene Rbpsuh-rs3 to chromosome 6. Cytogenet Cell Genet 2000;88:218-220.
56.
Weidenbach H, Leiz S, Nussler AK, Dikopoulos N, Bachem M, Buttenschoen K, Reinshagen M, Beger HG, Adler G, Schmid RM. Disturbed bile secretion and cytochrome P-450 function during the acute state of experimental colitis in rats. J Hepatol 2000;32:708-717
57.
Leiter U, Schmid RM, Kaskel P, Peter RU, Krahn G. Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma. Arch Dermatol Res 2000;292:225-232.
58.
Weber CK, Liptay S, Wirth T, Adler G, Schmid RM. Suppression of NF-?B activity by sulfasalazine is mediated by direct inhibition of I?B kinases alpha and beta. Gastroenterology 2000;119:1209-1218.
59.
Song Q, Spahr A, Schmid RM, Adler G, Bode G. Helicobacter pylori in the oral cavity: high prevalence and great DNA diversity. Digest Dis Sci 2000;45:2162-2167.
60.
Wagner M, Greten FR, Weber CK, f S, Mattfeldt T, Deppert W, Kern H, Adler G, Schmid RM. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001;15:286-293.
61.
Dikopoulos N, Nussler AK, Liptay S, M Bachem M, Reinshagen M, Stiegler M, Schmid, RM, Adler G, Weidenbach H. Inhibition of nitric oxide synthesis by aminoguanidine increased intestinal damage in the acute phase of rat TNB-colitis. Eur J Clin Invest.2001;31:234-239
62.
Seitz U, M Wagner M, Vogg AT, Glatting G, Neumaier B, Greten FR, Schmid RM, Reske SN. In vivo evaluation of 5-[18F]Fluoro-2’-deoxyuridine as tracer for positron emission tomography in a murine pancreatic cancer model. Cancer Res 2001;61:3853-3857.
63.
Ludwig L, H Kessler H, Wagner M, Hoang-Vu C, Dralle H, Adler G, Bohm BO, Schmid RM. Nuclear Factor-?B is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res 2001;61:4526-4535.
64.
Schneider E, Schmid-Kotsas A, Zhao J, Weidenbach H, Schmid RM, Menke A, Adler G, Waltenberger J, Grunert A, Bachem MG. Identification of mediators stimulating activation, proliferation and matrix synthesis of cultured rat pancreatic stellate cells. Am J Physiol-Cell PH 2001;281:C532-C543.
65.
Schneiderhan W, A Schmid-Kotsas A, J Zhao J, A Grunert A, A Nussler A, H Weidenbach H, A Menke A, RM Schmid RM, G Adler G, MG Bachem MG. Oxidized Iow-density lipoproteins bind to scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis. Hepatology 2001;34:729-737.
66.
Oswald  F, Tauber B, Dobner T, Bourteele S, Adler G, Liptay S, Schmid RM. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol 2001;21:7761-7774.
67.
Gerhard M, Schmid RM, Hacker G. Analysis of the cytochrome c-dependent apoptosis apparatus in cells from human pancreatic carcinoma. Brit J Cancer 2002;86:893-898.
68.
Seufferlein T, Seckl MJ, Schwarz E, Beil M, von Wichert G, Baust H, Luhrs H, Schmid RM, Adler G. Mechanisms of nordihydroguaiaretic acid-induced growth inhibition and apoptosis in human cancer cells. Brit J Cancer 2002;86:1188-1196.
69.
Paxian S, Merkle H, Riemann M, Wilda M, Adler G, Hameister H, Liptay S, Pfeffer K, Schmid RM. Abnormal organogenesis of peyer's patches in mice deficient for NF-?B1, NF-?B2, and Bcl-3. Gastroenterology 2002;122:1853-1868.
70.
Wagner M, Weber CK, Bressau F, Greten FR, Stagge V, Ebert M, Leach SD, Adler G, Schmid RM. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. Gastroenterology 2002;122:1898-1912.
71.
Algul  H, Y Tando Y, Beil M, Weber CK, von Weyhern C, Schneider G, Adler G, Schmid RM. Different modes of NF-?B/Rel activation in pancreatic lobules. Am J Physiol-Gastr L 2002;283:G270-G281.
72.
Seitz U, Wagner M, Neumaier B, Wawra E, Glatting G, Leder G, Schmid RM, Reske SN. Evaluation of Pyrimide metabolising Enzymes and in vitro uptake of 3’-[(18)F]fluoro-3’-deoxythymidine ([F]FLT) in pancreatic cancer cell lines. Eur J Nucl Med Mol I 2002;29:1174-1181.
73.
Schneider G, Oswald F, Wahl C, Greten FR, Adler G, Schmid RM. Cyclosporine inhibits growth through the ATF/CREB binding site in the cycline D1 promoter. J Biol Chem 2002;277:43599-43607.
74.
Oswald F, Kostezka U, Astrahantseff K, Bourteele S, Dillinger K, Zechner U, Ludwig L, Wilda M, Hameister H, Knochel W, Liptay S, Schmid RM. SHARP is a novel component of the Notch/RBP-J? signalling pathway. EMBO J 2002;21:5417-5426.
75.
Liptay S, Fulda S, Schanbacher M, Bourteele S, Ferri KF, Kroemer G, Adler G, Debatin KM, Schmid RM. Molecular mechanisms of sulfasalazine-induced T-cell apoptosis. Brit J Pharmacol 2002;137:608620.
76.
Munzert G, Kirchner D, Stobbe H, Bergmann L, Schmid RM, Dohner H, Heimpel H. Tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-?B/Rel regulated Inhibitors of apoptosis. Blood 2002;100:3749-3756.
77.
Greten  FR, Weber CK, Schneider G, Wagner M, Adler G, Schmid RM. Stat3 and NF-?B activation prevents apoptosis in pancreatic carcinogenesis. Gastroenterology 2002;123:2052-2063.
2003
78.
Dikopoulos N, Weidenbach H, Adler G, Schmid RM. Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II. Eur J Clin Invest 2003;33:58-64.
79.
Tando Y, Algul H, Schneider G, Weber CK, Weidenbach H, Adler G, Schmid RM. Induction of I?B-kinase by cholecystokinin is mediated by Trypsinogen activation in rat pancreatic lobules. Digestion 2003;66:237245.
80.
Liptay S, Weber CK, Ludwig L, Wagner M, Adler G, Schmid RM. Mitogenic and antiapoptotic role of constitutive NF-?B/Rel activity in pancreatic cancer. Int J Cancer 2003;105:735-746.
81.
Hasel C, Durr S, Rau B, Strater J, Schmid RM, Walczak H, Bachem MG, Moller P. In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas. Lab Invest 2003;83:825836.
82.
Kirchner D, Duyster J, Ottmann O, Schmid RM, Bergmann L, Munzert G. Mechanisms of Bcr-Abl-mediated NF-?B/Rel activation. Exp Hematol 2003;31:504-511.
83.
Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, IacobuzioDonahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SD. Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003;3:565-576.
84.
Ludwig L, Kessler H, Hoang-Vu C, Dralle H, Adler G, Boehm BO, Schmid RM. Grap-2, a novel RET binding protein, is involved in RET mitogenic signaling. Oncogene 2003;22:5362-5366.
85.
Schreiner B, Baur DM, Fingerle AA, Zechner U, Greten FR, Adler G, Sipos B, Kloppel G, Hameister H, Schmid RM. Pattern of secondary genomic changes in pancreatic tumors of Tgf alpha/Trp53+/- transgenetic mice. Genes Chromosomes Cancer 2003;38:240-248.
86.
Schreiner B, Greten FR, Baur DM, Fingerle AA, Zechner U, Bohm C, Schmid M, Hameister H, Schmid RM. Murine pancreatic tumor cell line TD2 bears the characteristic pattern of genetic changes with two independently amplified gene loci. Oncogene 2003;22:6802-6809.
87.
Baust H, Schoke A, Brey A, Gern U, Los M, Schmid RM, Rottinger EM, T Seufferlein T. Evidence for radiosensitzing by gliotoxin in HL-60 cells: implications for a role of NF-?B independent mechanisms. Oncogene 2003;22:8786-8796.
88.
Weidenbach H, Orth M, Adler G, Mertens T, Schmid RM. Treatment of chronic hepatitis B with high-dose intravenous N-acetyl-L-cysteine. Hepato-Gastroenterol 2003;50:2105-2108.
2004
89.
Saur D, Vanderwinden JM, Seidler B, Schmid RM, De Laet MH, Allescher HD. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1 c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci U S A. 2004;101:1662-1667.
90.
Munzert G, Kirchner D, Ottmann O, L Bergmann L, Schmid RM. Constitutive NF-?B/Rel activation in Ph+ acute lymphoblastic leukemia (ALL). Leukemia Lymphoma 2004;45:1181-1184.
2005
91.
Haussler U, von Wichert G, Schmid RM, Keller F, Schneider G. Epidermal growth factor (EGF) activates nuclear factor (kappa) b in human proximal tuble cells. Am J Physiol-Renal 2005;289:F808-815.
92.
Geisler F, Algul H, Riemann M, Schmid RM. Questioning current concepts in acute pancreatitis: endotoxin contamination of porcine pancreatic elastase is responsible for experimental pancreatitis-associated distant organ failure. J Immunol 2005;174:6431-6439.
93.
von Delius S, Lersch C, Schulte-Frohlinde E, Mayr M, Schmid RM, Eckel F. Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma. BMC Cancer 2005;5(1):61.
94.
Riemann M, Endres R, Liptay S, Pfeffer K, Schmid RM. The IkappaB protein Bcl-3 regulates transcription of the IL-10 gene in macrophages. J Immunol 2005;175:3560-3568 .
95.
Saur D, Seidler B, Schneider G, Algul H, Beck R, SenekowitschSchmidtke R, Schwaiger M, Schmid RM. CXCR4 expression increases liver and lung metastasis in a mouse model
of pancreatic cancer. Gastroenterology 2005;129:1237-1250.
96.
Bajbouj M, Reichenberger J, Neu B, Prinz C, Schmid RM, Rosch T, Meining A. A prospective multicenter clinical and endoscopic follow-up study of patients with astroesophageal reflux disease. Z Gastroenterol. 2005;43:1303-1307.
97.
Eckel F, von Delius S, Mayr M, Dobritz M, Hosius C, Schleyer E, Schulte-Frohlinde E, Schmid RM, Lersch C. Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology-Basel 2005;69:363-371.
2006
98.
Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S. GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability. Int J Cancer 2006;118:2405-2144.
99.
Savarese E, Chae OW, Trowitzsch S, Weber G, Kastner B, Akira S, Wagner H, Schmid RM, Bauer S, Krug A. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells via TLR7U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells via TLR7. Blood 2006;107:3229-3234.
100.
Garbe AI, Vermeer B, Gamrekelashvili J, v Wasielewski R, Greten FR, Westendorf AM, Buer J, Schmid RM, Manns MP, Korangy F, Greten TF. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses. Cancer Res 2006;66:508-516.
101.
Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining M, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology 2006;239:793-804.
102.
Meining A, Bajbouj M, Preeg M, Reichenberger J, Kassem AM, Huber W, Brockmeyer SJ, Hannig C, Höfler H, Prinz C, Schmid RM. Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 2006;38:566-570.
103.
Bauer A, Villunger A, Labi V, Fischer SF, Strasser A, Schmid RM, Hacker G. The NF-?B regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci U S A 2006 103:10979-10984.
104.
Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006;131:525-537.
105.
Schneider G, Saur D, Siveke JT, Fritsch R, Greten FR, Schmid RM. IKK? controls p52/RelB at the skp2 gene promoter to regulate G1 to S Phase Progression. EMBO J 2006;25:3801-3812.
106.
Dossumbekova A, Prinz C, Gerhard M, Brenner L, Backert S, Kusters JG, Schmid RM, Rad R. Helicobacter pylori outer membrane proteins and gastric inflammation. Gut 2006;55:1360-1361.
107.
Friedrich MJ, Rad R, Langer R, Voland P, Hoefler H, Schmid RM, Prinz C, Gerhard M. Lack of RUNX3 regulation in human gastric cancer. J Pathol 2006;210:141-146.
108.
von Delius S, Feussner H, Schmid RM, Frimberger E. Is electromagnetic navigation useful for Routine Colonoscopy? Endosk heute 2006;19:23-25.
2007
109.
von Delius S, Eckel F, Wagenpfeil S, Mayr M, Stock K, Kullmann F, Obermeier F, Ermann J, Schmelz R, Quasthoff S, Adelsberger H, Bredenkamp R, Schmid RM, Lersch C. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: Final results of a randomized, controlled, multicenter phase II study. Invest New Drugs 2007;25:173-180.
110.
Fahrig R, Quietzsch D, Heinrich JC, Heinemann V, Boeck S, Schmid RM, Praha C, Liebert A, Sonntag D, Krupitza G, Haenel M. RP101 improves the efficacy of chemotherapy in pancreas carcinoma cell lines and pancreatic cancer patients. Anticancer Drugs 2006;17:1045-1056.
111.
Dossumbekova A, Prinz C, Mages J, Lang R, Kusters JG, van Vliet AH, Reindl W, Backert S, Saur D, Schmid RM, Rad R. Helicobacter pylori HopH (OiPA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms. J Infect Dis 2006;194:1346-1355.
112.
Inta I, Paxian S, Maegele I, Zhang W, Pizzi M, Spano P, Sarnico I, Muhammad S, Herrmann O, Inta D, Baumann B, Liou HC, Schmid RM, Schwaninger M. Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappaB subunit RelA in cerebral schemia. J Neurosci 2006;26:12896-903.
113.
Meining A, Semmler V, Kassem AM, Sander R, Frankenberger U, Burzin M, Reichenberger J, Bajbouj M, Prinz C, Schmid RM. The effect of sedation on the quality of upper gastrointestinal endoscopy: an investigator-blinded, randomized study comparing propofol with midazolam. Endoscopy 2007;39:345-349.
114.
Nakhai H, Sel S, Favor J, Mendoza-Torres L, Paulsen F, Duncker GI, Schmid RM. Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina. Development 2007;134:1151-1160.
115.
Retzer-Lidl M, Schmid RM, Schneider G. Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes toward TRAIL-induced apoptosis via downregulation of survivin. Int J Cancer 2007;121:2820-2829.
116.
Umgelter A. Reindl W, Schmid RM, Huber W. Is supra-ventricular arrhythmia a reason for the bad performance of the FlowTrac device? Crit Care 2007;11:406.
117.
Eckel F, Schmid RM. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br J Cancer 2007;96:896-902.
118.
Dikopoulos N, Schmid RM, Bachem M, Buttenschoen K, Adler G, Chiang JYL, Weidenbach H. Bile synthesis in rat models of inflammatory bowel diseases. Eur J Clin Invest. 2007;37:222-230.
119.
Frimberger E, von Delius S, Rosch T, Schmid RM. Colonoscopy and polypectomy with a side-viewing endoscope. Endoscopy 2007;39:462-465.
120.
Weber A, Schneider J, Neu B, Meining A, Born P, Schmid RM, Prinz C. Endoscopic stent therapy of patients with chronic pancreatitis: results from a prospective follow up study. Pancreas 2007;34:287-294.
121.
Umgelter A, Huber W. Schmid RM, Reindl W. Coma as a presenting symptom of primary HIV infection. Sex Transm Infect 2007;83:85-86.
122.
Weber A, Landrock S, Schneider J, Stangl M, Neu B, Born P, Classen M, Rosch T. Schmid RM, Prinz C. Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol 2007;13:1422-1426.
123.
Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res 2007;67:4149-4156.
124.
Schmees C, Prinz C, Treptau T, Rad R, Hengst L, Voland P, Bauer S, Brenner L, Schmid RM, Gerhard M. Inhibition of T-cell proliferation by helicobacter pylori gamma-glutamyl transpeptidase. Gastroenterology 2007;132:1820-1833.
125.
von Delius S, Hollweck R, Schmid RM, Frimberger E. Midazolam-pain, but one cannot remember it: a survey among Southern German endoscopists. Eur J Gastroenterol Hepatol 2007;19:465-470.
126.
Kolb S, Fritsch R, Saur D, Reichert M, Schmid RM, Schneider G. HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells. Cancer Res 2007;67:4679-4686.
127.
Algul H, Treiber M, Lesina M, Schmid RM. Mechanisms of disease: chronic inflammation and cancer in the pancreas—a potential role for pancreatic stellate cells? Nat Clin Pract Gastroenterol Hepatol 2007;4:454-462
128.
von Delius S, Feussner H, Wilhelm D, Karagianni A, Henke J, Schmid RM, Meining A. Transgastric in-vivo histology in the peritoneal cavity using miniprobe-based confocal fluorescence microscopy in an acute porcine model. Endoscopy 2007;39:407-411.
129.
Meining A, Schwendy S, Becker V, Schmid RM, Prinz C. In vivo histopathology of lymphocytic colitis. Gastrointest Endosc 2007;66:398-399
130.
Algul H, Treiber M, Lesina M, Nakhai H, Saur D, Geisler F, Pfeifer A, Paxian S, Schmid RM. Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis. J Clin Invest 2007;117:1490-1501
131.
von Delius S, Feussner H, Henke J, Schneider A, Hollweck R, Rosch T, Prinz C, Schmid RM, Frimberger E. Submucosal endoscopy – a novel approach to en block endoscopic mucosal resection (with videos). Gastrointest Endosc 2007 [Epub ahead of print]
132.
Algul H, Wagner M, Lesina M, Schmid RM. Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation. Int J Cancer 2007;121:1410-1016
133.
Fritsch RM, Schneider G, Saur D, Scheibel M, Schmid RM. Translational repression of MCL-1 couples the integrated stress response to mitochondrial apoptosis initiation. J Biol Chem 2007;282:22551-22562
134.
Geisler F, Algul H, Paxian S, Schmid RM. Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology. 2007;132:2489-2503
135.
Bourteele S, Oesterle K, Weinzierl A, Paxian S, Riemann M, Schmid RM, Planz O. Alteration of NF-?B activity leads to mitochondrial apoptosis after infection with pathological prion protein. Cell Microbiol 2007;9:2002-2017
136.
Rad R, Brenner L, Krug A, Voland P, Mages J, Lang R, Schwendy S, Reindl W, Dossumbekova A, Ballhorn W, Wagner H, Schmid RM, Bauer S, Prinz C. Toll-like receptor dependent activation of antigen presenting cells affects adaptive immunity to Helicobacter pylori. Gastroenterology 2007;133:150-163.e3
137.
Schneider G, Reichert M, Saur D, Hamacher R, Fritsch R, Schmid RM. HDAC3 is linked to the cell cycle machinery in MiaPaCa2 cells by regulating the transcription of skp2. Cell Proliferat 2007;40:522-531
138.
Aichler M, Alguel H, Behne D, Hoelzlwimmer G, Michalke B, QuintaniellaMartinez L, Schmidt J, Schmid RM, Brielmeier M. Selenium supplementation in mice influences phenotype, but not incidence or latency of pancreatic adenocarcinomas in the Ela-TGF-? p53+/- tumour model. Carcinogenesis 2007;28:2002-2007.
139.
Hamacher R, Saur D, Fritsch R, Reichert M, Schmid RM, Schneider G. Casein Kinase II inhibition induces apoptosis in pancreatic cancer cells. Oncology Rep 2007;18:695-701
140.
Meining A, Saur D, Bajbouj M, Becker V, Peltier E, Hofler H, van Weyhern CH, Schmid RM, Prinz C. In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis. Clinical Gastroenterol Hepatol 2007;5:1261-1267.
141.
Schulte-Frohlinde E, Wagenpfeil S, Willis J, Lersch C, Eckel F, Schmid R, Schusdziarra V. Role of meal carbohydrate content for the imbalance of plasma amino acids in patients with liver cirrhosis. J Gastroenterol Hepatol. 2007; 22:1241-1248.
142.
Rebholz B, Haase I, Eckelt B, Paxian S, Flaig MJ, Ghoreschi K, Nedospasov SA, Mailhammer R, Debey-Pascher S, Schultze JL, Weindl G, Foerster I, Huss R, Stratis A, Ruzicka T, Roecken M, Pfeffer K, Schmid RM, Rupec RA. Crosstalk between keratinocytes and adaptive immune cells in an I?B? protein-mediated inflammatory disease of the skin. Immunity 2007;27:296-307
143.
von Delius S, Ayvaz MA, Wagenpfeil S, Eckel F, Schmid RM, Lersch C. Effect of low molecular weight heparin on survival in patients with advanced pancreatic adenocarcinoma. Thromb Haemost. 2007;98:434439
144.
Becker V, Vercauteren T, von Weyhern CH, Prinz C, Schmid RM, Meining A. High resolution miniprobe-based confocal microscopy in combination with video mosaicing. Gastrointest Endosc 2007;1-7
145.
Siveke J, Einwachter H, Sipos B, Saur D, Kloppel G, Schmid RM. Concomitant pancreatic activation of KrasG12D and Tgf? results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell. 2007;12:266-279.
146.
Greten F, Arkan MC, Bollrath J, Hsu LC, Goode J, Mieting C, Serkan IG, Neuenhahn M, Fierer J, Paxian S, van Rooijen N, Xu Y, O’ Cain T, Jaffee BB, Busch DH, Duyster J, Schmid RM, Eckmann L, Karin M. NF-?B is a negative regulator of IL-1? secretion as revealed by genetic and pharmacological inhibition of IKK?. Cell. 2007;130:918-931.
147.
Burgermeister E, Xing X, Rocken C, Juhasz M, Chen J, Hiber M, Mair K, Shatz M, Liscovitch M, Schmid RM, Ebert MPA. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res. 2007;67:8519-8526.
148.
Becker V, Bajbouj M, Waller K, Schmid RM, Meining A. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors – a floow-up study of intraluminal-impedance guided therapy. Aliment Pharmacol Ther. 2007;15:1355-1360.
149.
Umgelter A, Reindl W, Schmid RM, Huber W. Continuous terlipressin infusion in patients with persistent septic shock and cirrhosis of the liver. Intensive Care Med. 2007; Oct 5 [Epub ahead of print]
150.
von Delius S, Huber W, Feussner H, Wilhelm D, Karagianni A, Henke J, Preissel A, Schneider A, Schmid RM, Meining A. Effect of pneumoperitoneum in hemodynamics and inspiratory pressures during NOTES: An experimental, controlled study in an acute porcine model. Endoscopy. 2007;39:854-61.
151.
von Delius S, Karagianni A, Henke J, Meining A, Schmid RM. Changes in intraabdominal pressure, hemodynamics and peak inspiratory pressure during gastroscopy in a procine model. Endoscopy. 2007;39:962968.
152.
Huber W, Umgelter A, Schuster T, Schmid RM. The pancreatic outcome prediction (POP) score: how about hematocrit and leukopenia? Crit Care Med. 2007;35:2670-2671.
153.
Meining A, Wilhelm D, Burian M, Dundoulakis M, Schneider A, von Delius S, Feussner H. Development, standardization, and evaluation of NOTES cholecystectomy using a transsigmoid approach in the porcine model: an acute feasibility study. Endoscopy 2007;39:860-864
154.
Lang MF, Schneider A, Kruger C, Schmid R, Dziarski R, Schwaninger M. Peptidoglycan recognition protein-S (PGRP-S) is upregulated by NFkappaB. Neurosc Lett. 2007 Nov 1 [Epub ahead of print]
155.
Adler G, Seufferlein T, Bischoff SC, Brambs HJ, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I. Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies. Dtsch Med Wochenschr. 2007;132:1696-1700.
156.
Adler G, Seufferlein T, Bischoff SC, Brambs HJ, Feuerbach S, Grabenbauer G, Hahn S, Heinemann V, Hohenberger W, Langrehr JM, Lutz MP, Micke O, Neuhaus H, Neuhaus P, Oettle H, Schlag PM, Schmid R, Schmiegel W, Schlottmann K, Werner J, Wiedenmann B, Kopp I. S3-Guidelines “Exocrine pancreatic cancer” 2007. Z Gastroenterol. 2007;45:487-523.
2008
157.
Umgelter A, Schmid RM, Huber W. Avoiding the V-word: is volume therapy in hepatorenal syndrome killed by definition? Gut. 2008;57:138139.
158.
Siveke JT, Lubeseder-Martellato C, Lee M, Mazur PK, Nakhai H, Radtke F, Schmid RM. Notch signaling is required for exocrine regeneration after acute pancreatitis. Gastroenterology. 2008;134:544-555.
159.
Weber A, Roesch T, Pointner S, Born P, Neu B, Meining A, Schmid RM, Prinz C. Transpancreatic precut sphincterotomy for cannulation of inaccessible common bile duct: a safe and successful technique. Pancreas, 2008, in press
160.
Weber A, von Weyhern C, Fend F, Schneider J, Neu B, Meining A, Weidenbach H, Schmid RM, Prinz C. Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinoma.
World J Gastroenterol, 2008, in press
161.
Frimberger E, von Delius S, Rosch T, Karagianni A, Schmid RM, Prinz C. A novel and practicable ERCP training system with simulated fluoroscopy.
Endoscopy, 2008, in press
162.
Wilhelm D, von Delius S, Burian , Frimberger E, Meining A, Feussner H. Combined laparoscopic-endoscopic „rendez-vous“ resection of gastric subepithelial masses – an analyses of 93 interventions.
World J Surg, 2008, in press
163.
von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM, Eckel F. Capecitabine for treatment of advanced hepatocellular carcinoma. Hepato-Gastroenterology, 2008, in press
164.
Prinz C, Voland P, Besig S, Rad R, Braun T, Baur D, Langer R, Hoefler H, Schmid RM. Expression of MMPs and TIMPs in midgut carcinoids, lymph nodes and liver metastasis.
Neuroendocrinology, 2008, accepted for publication
165.
von Delius S, Karagianni A, von Weyhern, CH, Feussner, H, Schuster T, Schmid RM, Frimberger E. Percutaneously assisted endoscopic surgery (PA-ES) using a new PEG-minitrokar for advanced endoscopic submucosal dissection.
Endoscopy, 2008, accepted for publication
166.
Becker V, von Delius S, Bajbouj M, Karagianni A, Schmid RM, Meining A. “Intravenous application of fluorescein for confocal laser scanning microscopy: evaluation of contrast dynamics and image quality with increasing injection-to-imaging time.
GI Endoscopy, 2008, accepted for publication
167.
Umgelter A, Reindl W, Wagner K, Franzen M, Stock K, Schmid RM, Huber W. Effects of plasma expansion with albumin and paracentesis on hemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepato-renal syndrome: a prospective unconrolled trial. Crit Care, 2008, accepted for publication.
168.
Weber A, Huber W, Kamereck K, Winkle P, Voland P, Weidenbach H, Schmid RM, Prinz C. In vitro activitiy of moxifloxacin and piperacillin/sulbactam against pathogens of acute bacterial cholangitis.
World J Gastroenterol, 2008, accepted for publication
169.
von Delius S, Gillen S, Doundoulakis E, Schneider E, Wilhelm D, Fiolka A, Wagenpfeil S, Schmid RM, Feussner H, Meining A. Comparison of transgastric access techniques for Natural Orifice Translumenal Endoscopic Surgery (NOTES).
Gastrointest Endosc, 2008, accepted for publication





Impressum

2013 · Klinikum rechts der Isar der Technischen Universität München